Histone deacetylase inhibitor trichostatin A induced caspase- independent apoptosis in human gastric cancer cell

Chinese Medical Journal

Volumn 120, Issue 23, 2007, Pages 2112-2118

  Wu, Zhi Qun ^a,b   Zhang, Rui ^b   Chao, Connie ^c   Zhang, Ji Feng ^a   Zhang, Yuan Qiang ^b  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^c SECTION OF MOLECULAR BIOLOGY   (United States)

Author keywords

Apoptosis; Gastric cancer; Histone deacetylase inhibitor; Trichostatin A

Indexed keywords

APOPTOSIS INDUCING FACTOR; BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; CASPASE INHIBITOR; FLUORESCEIN ISOTHIOCYANATE; HISTONE DEACETYLASE INHIBITOR; LIPOCORTIN 5; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN BAX; PROTEIN BCL 2; SURVIVIN; TRICHOSTATIN A;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER INHIBITION; CELL FRACTIONATION; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; MITOCHONDRION; NICK END LABELING; NUCLEOTIDE SEQUENCE; REAL TIME POLYMERASE CHAIN REACTION; STOMACH CANCER; WESTERN BLOTTING;

EID: 37249062152     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200712010-00009     Document Type: Article

References (22)

1. Souza RF, Spechler SJ. Concepts in the prevention of adenocarcinoma of the distal esophagus and proximal stomach. CA cancer J Clin 2005; 55: 334-351.
2. Carey N, La Thangue NB. Histone deacetylase inhibitors: gathering pace. Curr Opin Pharmacol 2006; 6: 369-375.
3. Suzuki T, Yokozaki H, Kuniyasu H, Hayashi K, Naka K, Ono S, et al. Effect of Trichostatin A on cell growth and expression of cell cycle-and apoptosis-related molecules in human gastric and oral carcinoma cell lines. Int J Cancer 2000; 88: 992-997.
4. Herold C, Ganslmayer M, Ocker M, Hermann M, Geerts A, Hahn EG, et al. The histone-deacetylase inhibitor trichostatin A blocks proliferation and triggers apoptotic programs in hepatoma cells. J Hepatol 2002; 36: 233-240.
5. WAF1/CIP1 and G1 cell cycle arrest. Int J Urol 2006; 13: 581-586.
6. Lin CH, Fu ZM, Liu YL, Yang JL, Xu JF, Chen QS, et al. Investigation of SGC-7901 cell line established from human gastric carcinoma cells. Chin Med J 1984; 97: 831-834.
7. Yasui W, Oue N, Ono S, Mitani Y, Ito F, Nakayama H. Histone acetylation and gastrointestinal carcinogenesis. Ann N Y Acad Sci 2003; 983: 220-231.
8. Maiso P, Carvajal-Vergara X, Ocio EM, Lopez-Perez R, Mateo G, Gutierrez N, et al. The histone deacetylase inhibitor LBH589 is a potent antimyeloma agent that overcomes drug resistance. Cancer Res 2006; 66: 5781-5789.
9. Karagiannis TC, El-Osta A. Modulation of cellular radiation responses by histone deacetylase inhibitors. Oncogene 2006; 25: 3885-3893.
10. Kwon HJ, Kim MS, Kim MJ, Nakajima H, Kim KW. Histone deacetylase inhibitor FK228 inhibits tumor angiogenesis. Int J Cancer 2002; 97: 290-296.
11. Fronsdal K, Saatcioglu F. Histone deacetylase inhibitors differentially mediate apoptosis in prostate cancer cells. Prostate 2005; 62: 299-306.
12. Dokmanovic M, Marks PA. Prospects: histone deacetylase inhibitors. J Cell Biochem 2005; 96: 293-304.
13. Daugas E, Susin SA, Zamzami N, Ferri KF, Irinopoulou T, Larochette N, et al. Mitochondrio-nuclear translocation of AIF in apoptosis and necrosis. FASEB J 2000; 14: 729-739.
14. Suzuki A, Tsutomi Y, Miura M, Akahane K, Caspase 3 inactivation to suppress Fas-mediated apoptosis: identification of binding domain with p21 and ILP and inactivation machiniery by p21. Oncogene 1999; 18: 1239-1244.
15. Van Loo G, Schotte P, van Gurp M, Demol H, Hoorelbeke B, Gevaert K, et al. Endonuclease G: a mitochondrial protein released in apoptosis and involved in caspase-independent DNA degradation. Cell Death Differ 2001; 8: 1136-1142.
16. Liu T, Brouha B, Grossman D. Rapid induction of mitochondrial events and caspase-independent apoptosis in survivin targeted melanoma cells. Oncogene 2004; 23: 39-48.
17. Okuno S, Shimizu S, Ito T, Nomura M, Hamada E, Tsujimoto Y, et al. Bcl-2 prevents caspase-independent cell death. J Bio Chem 1998; 273: 34272-34277.
18. Fitch ME, Chang CM, Parslow TG. The BH3 domain is required for caspase-independent cell death induced by Bax and oligomycin. Cell Death Differ 2000; 7: 338-349.
19. Shibata A, Parsonnet J, Longacre TA, Garcia MI, Puligandla B, Davis RE, et al. CagA status of Helicobacter pylori infection and p53 gene mutations in gastric adenocarcinoma. Carcinogenesis 2002; 23: 419-424.
20. Jiang XH, Wong BC, Lin MC, Zhu GH, Kung BF, Jiang SH, et al. Functional p53 is required for triptolide-induced apoptosis and AP-1 and nuclear factor-kappaB activation in gastric cancer cells. Oncogene 2001; 20: 8009-8018.
21. Takimoto R, Kato J, Terui T, Takada K, Kuroiwa G; Wu J, et al. Augmentation of antitumor effects of p53 gene therapy by combination with HDAC inhibitor. Cancer Biol Ther 2005; 4: 421-428.
22. Lee HS, Park MH, Yang SJ, Jung HY, Byun SS, Lee DS, et al. Expression profile analysis of trichostatin A in human gastric cancer cells. Biotechnology letter 2002; 24: 377-381.